Lila Sciences has raised $2.5B across 1 funding round, plus 2 undated rounds. The latest round valued Lila Sciences at $8.5B pre-money, with California Public Employees' Retirement System, Nvidia NVentures on the lead line.
Lila Sciences raised $200 million in seed funding led by Flagship Pioneering, the bioplatform innovation company that unveiled Lila in March 2025 after incubating it for two years in stealth.
1 funding round, the latest highlighted.
Lila Sciences was founded in 2025, United States.
No date is disclosed for this round.
A primary round — the company sells new shares to investors it selects. $2B raised, led by California Public Employees' Retirement System, Nvidia NVentures.
No filing has been made.
1 dated round, newest first.
Alumni VenturesThe routes section explains what is realistically available for a company at this stage.
No. Lila Sciences is a private company; its shares do not trade on a public exchange.
The closest biotechnology / ai peers are on the competitors page.
Perpetual markets for stocks, gold, indices and pre-IPO names — settled on-chain, no wallet-to-exchange transfers.
